Literature DB >> 10207016

Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus.

S Schmitt1, D Glebe, K Alving, T K Tolle, M Linder, H Geyer, D Linder, J Peter-Katalinic, W H Gerlich, R Geyer.   

Abstract

The surface antigen of hepatitis B virus comprises a nested set of small (S), middle (M), and large (L) proteins, all of which are partially glycosylated in their S domains. The pre-S2 domain, present only in M and L proteins, is further N-glycosylated at Asn-4 exclusively in the M protein. Since the pre-S2 N-glycan appears to play a crucial role in the secretion of viral particles, the M protein may be considered as a potential target for antiviral therapy. For characterization of the pre-S2 glycosylation, pre-S2 (glyco)peptides were released from native, patient-derived hepatitis B virus subviral particles by tryptic digestion, separated from remaining particles, purified by reversed-phase high performance liquid chromatography, and identified by amino acid and N-terminal sequence analysis as well as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Pre-S2 N-glycans were characterized by anion exchange chromatography, methylation analysis, and on target sequential exoglycosidase digestions in combination with MALDI-TOF-MS, demonstrating the presence of partially sialylated diantennary complex-type oligosaccharides. In addition, the pre-S2 domain of M protein, but not that of L protein, was found to be partially O-glycosylated by a Gal(beta1-3)GalNAcalpha-, Neu5Ac(alpha2-3)Gal(beta1-3)GalNAcalpha-, or GalNAcalpha-residue. The respective O-glycosylation site was assigned to Thr-37 by digestion with carboxypeptidases in combination with MALDI-TOF-MS and by quadrupole time-of-flight electrospray mass spectrometry. Analytical data further revealed that about 90% of M protein is N-terminally acetylated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207016     DOI: 10.1074/jbc.274.17.11945

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

Review 3.  Variations and mutations in the hepatitis B virus genome and their associations with clinical characteristics.

Authors:  Yoshihiko Yano; Takeshi Azuma; Yoshitake Hayashi
Journal:  World J Hepatol       Date:  2015-03-27

4.  A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus.

Authors:  P Chouteau; J Le Seyec; I Cannie; M Nassal; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection.

Authors:  Jung Sun Yum; Byung Cheol Ahn; Hyun Jin Jo; Dong Yeon Kim; Ki Hyun Kim; Hyo Sun Kim; Young Chul Sung; Jaeseung Yoon; John Morrey; Hong Mo Moon
Journal:  Clin Vaccine Immunol       Date:  2011-12-07

6.  Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus.

Authors:  Manujendra N Saha; Atsushi Tanaka; Atsushi Jinno-Oue; Nobuaki Shimizu; Kazushi Tamura; Masahiko Shinagawa; Joe Chiba; Hiroo Hoshino
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Singlet oxygen affects the activity of the thylakoid ATP synthase and has a strong impact on its gamma subunit.

Authors:  Hanno Mahler; Petra Wuennenberg; Monica Linder; Dominika Przybyla; Christian Zoerb; Frank Landgraf; Christoph Forreiter
Journal:  Planta       Date:  2006-11-14       Impact factor: 4.116

8.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.

Authors:  Romain Julithe; Georges Abou-Jaoudé; Camille Sureau
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

10.  Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.

Authors:  Zhi-Mei Zhao; Yan Jin; Yu Gan; Yu Zhu; Tao-Yang Chen; Jin-Bing Wang; Yan Sun; Zhi-Gang Cao; Geng-Sun Qian; Hong Tu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.